Citation Impact
Citing Papers
Signal transduction to hypoxia-inducible factor 1
2002 StandoutNobel
Paracetamol: New Vistas of an Old Drug
2006
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice
2013 Standout
Beyond alcohol: Beverage consumption and cardiovascular mortality
1995
Coronary artery apoptosis in experimental hypercholesterolemia
1999
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Continuous Small-Dose Aprotinin Controls Fibrinolysis During Orthotopic Liver Transplantation
1996
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1α
1997 StandoutNobel
Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A165 in the uterine arteries of pregnant sheep
2011
Regulation of Cardiovascular Development and Physiology by Hypoxia‐Inducible Factor 1a
1999 StandoutNobel
Heme oxygenase–carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?
1999
Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes
2002 StandoutNobel
HIF-1 and mechanisms of hypoxia sensing
2001 StandoutNobel
High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery
2000
Atherothrombosis and High-Risk Plaque
2005
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Selection and Analysis of a Mutant Cell Line Defective in the Hypoxia-inducible Factor-1 α-Subunit (HIF-1α)
1998 StandoutNobel
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Structural and functional analysis of hypoxia-inducible factor 1
1997 StandoutNobel
Clinical Applications of Research on Angiogenesis
1995 Standout
Paracetamol (acetaminophen) poisoning
1995
Mammalian oxygen sensing and hypoxia inducible factor-1
1997 StandoutNobel
Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
2005
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
2001 StandoutNobel
Hypoxia-Inducible Factor 1
1998 StandoutNobel
Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double-blind study
2001
Molecular regulation of vessel maturation
2003 Standout
Acetaminophen‐induced acute liver failure
2005 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Paracetamol (acetaminophen) poisoning
1993
new understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging
2003
Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60
1997
Complete Inhibition of Intimal Hyperplasia by Perivascular Delivery of Paclitaxel in Balloon-injured Rat Carotid Arteries
2001
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Arterial wall injury in giant cell arteritis
1999
Aprotinin in coronary operation with cardiopulmonary bypass: does “low-dose” aprotinin inhibit the inflammatory response?
2002
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation
2000 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
2000 StandoutNobel
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Hypoxia-Inducible Factor-1α/Vascular Endothelial Growth Factor Pathway for Adventitial Vasa Vasorum Formation in Hypertensive Rat Aorta
2002
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified?
1997
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Angiogenesis in human coronary atherosclerotic plaques.
1994
Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling
2001
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
1997 StandoutNobel
Defining Physiological Normoxia for Improved Translation of Cell Physiology to Animal Models and Humans
2018
Effect of Atherosclerosis on Transmural Convection and Arterial Ultrastructure
1997
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
G Protein Signaling and Vein Graft Intimal Hyperplasia
1998 StandoutNobel
Evidence that atriopeptin is not a physiological regulator of sodium excretion.
1990
Influence of External Stent Size on Early Medial and Neointimal Thickening in a Pig Model of Saphenous Vein Bypass Grafting
1996
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Vascular Smooth Muscle Cells in Atherosclerosis
2016 Standout
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
2002 Standout
Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1
1999 StandoutNobel
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
1999 StandoutNobel
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
Hypoxia-inducible factor 1: master regulator of O2 homeostasis
1998 StandoutNobel
Genetic Decreases in Atrial Natriuretic Peptide and Salt-Sensitive Hypertension
1995 StandoutScienceNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Prediction of Hepatic Encephalopathy in Paracetamol Overdose: A Prospective and Validated Study
1999
Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase Expression
1998 Standout
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Etiology and outcome for 295 patients with acute liver failure in the united states
1999
Oxygen Sensing, Hypoxia-Inducible Factor-1 and the Regulation of Mammalian Gene Expression
1998 StandoutNobel
Pathobiology of intimal hyperplasia
1994
The Reactive Adventitia
2002
Works of Simon Cottam being referenced
Complement activation during major surgery: The effect of extracorporeal circuits and high-dose aprotinin
1998
Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation
1995
Coagulation and Fibrinolysis in Primary Biliary Cirrhosis Compared With Other Liver Disease and During Orthotopic Liver Transplantation
1997
Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease
2013
Liver transplantation after paracetamol overdose.
1991
Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig.
1993
Effect of a meal containing protein on lithium clearance and plasma immunoreactive atrial natriuretic peptide in man
1988
Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation.
1991